ARS Pharmaceuticals, Inc share price logo

ARS Pharmaceuticals, Inc

NASDAQ: SPRY

Small Cap

$8.54

+0.29

(+3.45%)

as on

ARS Pharmaceuticals, Inc Stock Performance

as on May 2, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $8.12
    $8.63
    downward going graph

    4.92%

    Downside

    1.05%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.66
    $18.90
    downward going graph

    22.01%

    Downside

    121.31%

    Upside

    downward going graph

ARS Pharmaceuticals, Inc share price movements today

Previous Close
$8.26
Open
$8.23
Volume
1.5M
Day's Low - High
$8.12 - $8.63
52 Week Low - High
$6.66 - $18.90

ARS Pharmaceuticals, Inc Historical Returns

1 Month Return
+ 3.13 %
3 Month Return
-16.89 %
1 Year Return
-40.8 %
3 Year Return
+ 31.29 %
5 Year Return
0 %

ARS Pharmaceuticals, Inc Stock Fundamentals & Key Indicators

Check ARS Pharmaceuticals, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$850.0M

EPS (TTM)

-1.5675

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-178.1M

Revenue (TTM)

84.3M

Profit Margin

-203.25%

Return On Equity TTM

-92.33%

ARS Pharmaceuticals, Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ARS Pharmaceuticals, Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
ARS Pharmaceuticals, Inc image
ARS Pharmaceuticals, Inc
BUY$850.0MNANA-203.25%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.3B110.54%77.5712.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$108.7B94.28%27.9332.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA118.495.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.1B45.73%17.2729.65%

Stock Returns calculator for ARS Pharmaceuticals, Inc Stock including INR - Dollar returns

The ARS Pharmaceuticals, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

ARS Pharmaceuticals, Inc investment value today

Current value as on today

₹66,244

Returns

-₹33,756

(-33.76%)

Returns from ARS Pharmaceuticals, Inc Stock

-₹40,941 (-40.94%)

Dollar Impact

₹7,184 (+7.18%)

Analyst Recommendation on ARS Pharmaceuticals, Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for ARS Pharmaceuticals, Inc. Average target price of $26.71

ARS Pharmaceuticals, Inc Share Price Target

Get share price movements and forecasts by analysts on ARS Pharmaceuticals, Inc.

What analysts predicted

68.03%UPSIDE

Target Price

$26.71

Current Price

$8.54

Analyzed by

9 Analysts

Target

$26.71

ARS Pharmaceuticals, Inc target price $26.71, a slight upside of 68.03% compared to current price of $8.54. According to 9 analysts rating.

ARS Pharmaceuticals, Inc Stock’s Investor Sentiment and Interest

Search interest for ARS Pharmaceuticals, Inc Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-18% versus previous 30 day period

ARS Pharmaceuticals, Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
0
2
86
7
15
32
28
Gross Profit
-3
-3
-5
0
1
82
3
10
24
24
Operating Income
-17
-10
-13
-15
-21
47
-37
-47
-53
-41
EBITDA
-17
-10
-13
-15
-21
47
-36
-44
-48
-41
Interest Expense
-
3
-
-
-
-
-
-
-
2
Depreciation
0
-6
-1
-1
-1
-1
-1
-1
0
0
Income Before Tax
-14
-7
-10
-12
-19
50
-33
-44
-51
-41
Income Tax Expense
0
3
0
-
-
0
-
-
-
0
Net Income
-14
-7
-10
-12
-19
49
-33
-44
-51
-41
Net Profit Margin
0.00%
23893.33%
0.00%
-2503.20%
-924.95%
57.67%
-425.69%
-285.57%
-157.38%
-147.13%

ARS Pharmaceuticals, Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
17
5
1
0
89
84
Gross Profit
3
5
-15
0
68
63
Operating Income
0
-19
-35
-67
-3
-179
EBITDA
0
-19
-35
-67
-3
-178
Interest Expense
0
0
0
-
-
2
Depreciation
0
0
0
0
-7
-4
Income Before Tax
-1
-20
-34
-54
8
-171
Income Tax Expense
0
0
0
0
0
0
Net Income
-1
-20
-34
-54
7
-171
Net Profit Margin
-5.97%
-367.65%
-2635.41%
-181216.67%
8.97%
-203.25%

ARS Pharmaceuticals, Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-7
-10
-12
-19
49
-33
-44
-51
-41
Operating Cash Flow
-17
-6
-7
-14
42
-40
-39
-47
-43
Investing Cash Flow
26
-8
-12
16
-101
29
48
-44
24
Financing Cash Flow
1
0
0
0
70
0
2
100
1
Change in Cash
10
-14
-19
3
11
-10
11
8
-18

ARS Pharmaceuticals, Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-23
-1
-20
-34
-54
7
-171
Operating Cash Flow
-18
9
-17
-40
-59
13
-170
Investing Cash Flow
0
0
0
0
-87
-106
56
Financing Cash Flow
8
5
53
190
6
72
104
Change in Cash
-10
14
35
150
-139
-20
-9

Global Institutional Holdings in ARS Pharmaceuticals, Inc

Funds
Holdings
Janney Montgomery Scott LLC
1.3%
BAMCO Inc
1.28%
Citadel Advisors Llc
1.6%
The Goldman Sachs Group Inc
0.82%
Orbimed Advisors, LLC
8.35%
See all

Insights on ARS Pharmaceuticals, Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -51.15M → -41.32M (in $), with an average increase of 23.8% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SPRY has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 56.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, SPRY stock has moved down by -40.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 32.50M → 28.08M (in $), with an average decrease of 13.6% per quarter

About ARS Pharmaceuticals, Inc

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
OrganisationARS Pharmaceuticals, Inc
Headquarters11682 El Camino Real, San Diego, CA, United States, 92130
IndustryBiotechnology
CEOMr. Richard E. Lowenthal M.B.A., M.S., MSMSEL
E-voting on sharesClick here to vote

Key Management of ARS Pharmaceuticals, Inc

Name

Title

Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL

Co-Founder, President, CEO & Director

Mr. Brian T. Dorsey M.S.

Chief Operating Officer

Dr. Robert Bell Ph.D.

Co-Founder & Chief Science Officer

Ms. Kathleen D. Scott CPA

Chief Financial Officer

Mr. Alexander A. Fitzpatrick Esq.

Chief Legal Officer & Secretary

Mr. Daniel Relovsky

Senior Vice President of Marketing

Dr. Sarina Tanimoto M.B.A., M.D.

Co-Founder & Chief Medical Officer

Ms. Lynda Harris

Vice President of Human Resources

Mr. Justin Chakma

Chief Business Officer

Mr. Eric Karas

Chief Commercial Officer

FAQs

What is ARS Pharmaceuticals, Inc share price today?

ARS Pharmaceuticals, Inc share price today is $8.54 as on at the close of the market. ARS Pharmaceuticals, Inc share today touched a day high of $8.63 and a low of $8.12.

What is the 52 week high and 52 week low for ARS Pharmaceuticals, Inc share?

ARS Pharmaceuticals, Inc share touched a 52 week high of $18.9 on and a 52 week low of $6.66 on . ARS Pharmaceuticals, Inc stock price today i.e. is closed at $8.54,which is 54.81% down from its 52 week high and 28.23% up from its 52 week low.

What is ARS Pharmaceuticals, Inc's market capitalisation today?

ARS Pharmaceuticals, Inc market capitalisation is $0.00T as on .

How to invest in ARS Pharmaceuticals, Inc Stock (SPRY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ARS Pharmaceuticals, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ARS Pharmaceuticals, Inc Shares that will get you 0.1756 shares as per ARS Pharmaceuticals, Inc share price of $8.54 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy ARS Pharmaceuticals, Inc Stock (SPRY) from India?

Indian investors can start investing in ARS Pharmaceuticals, Inc (SPRY) shares with as little as ₹94.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹948.80 in ARS Pharmaceuticals, Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on ARS Pharmaceuticals, Inc share’s latest price of $8.54 as on May 2, 2026 at 1:29 am IST, you will get 1.1710 shares of ARS Pharmaceuticals, Inc. Learn more about fractional shares .